BioLineRx Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	2.5	3.25	10.44	4.26	10.59	12.99
Short-Term Investments	14.85	17.63	9.13	38.74	40.5	44.15
Cash & Short-Term Investments	17.35	20.88	19.56	42.99	51.08	57.14
Cash Growth	-34.19%	6.72%	-54.50%	-15.83%	-10.59%	152.95%
Accounts Receivable	-	0.05	2.48	0.36	-	-
Other Receivables	1.89	0.41	1.48	0.83	0.72	0.14
Total Trade Receivables	1.89	0.46	3.95	1.19	0.72	0.14
Inventory	2.16	2.15	3.15	1.95	-	-
Other Current Assets	0.18	0.2	0.44	1.05	0.2	0.13
Total Current Assets	21.58	23.68	27.1	47.18	52	57.4
Net Property, Plant & Equipment	0.87	0.86	1.35	1.89	2.5	2.28
Other Intangible Assets	16.35	16.37	10.45	14.85	21.89	21.7
Total Assets	38.8	40.91	38.91	63.93	76.38	81.39
Accounts Payable	4.91	3.49	5.58	10.87	6.97	5.57
Accrued Expenses	2.25	1.74	3.13	3.35	1.74	1.23
Current Portion of Long-Term Debt	4.48	4.48	4.48	3.15	1.54	2.76
Current Portion of Leases	0.25	0.23	0.52	0.53	0.43	0.17
Unearned Revenue	-	-	-	12.96	-	-
Other Current Liabilities	1.74	2.17	1.69	11.93	-	-
Total Current Liabilities	13.62	12.12	15.41	42.78	10.68	9.72
Long-Term Debt	3.36	4.46	8.96	6.63	8.63	-
Long-Term Leases	0.98	0.98	1.08	1.29	1.73	1.73
Other Long-Term Liabilities	-	-	-	-	4.51	1.86
Total Long-Term Liabilities	4.34	5.44	10.04	7.92	14.86	3.59
Total Liabilities	17.96	17.56	25.45	50.7	25.54	13.3
Common Stock	73.43	73.43	38.1	31.36	27.1	21.07
Additional Paid-in Capital	347.26	347.19	376.61	373.89	355.15	353.48
Accumulated Other Comprehensive Income	-1.42	-1.42	-1.42	-1.42	-1.42	-1.42
Retained Earnings	-402.6	-401	-399.83	-390.61	-329.99	-305.04
Total Common Shareholders' Equity	16.67	18.2	13.46	13.22	50.84	68.09
Minority Interest	4.16	5.15	-	-	-	-
Shareholders' Equity	20.84	23.35	13.46	13.22	50.84	68.09
Total Liabilities & Equity	38.8	40.91	38.91	63.93	76.38	81.39
Total Debt	9.07	10.15	15.04	11.59	12.32	4.65
Net Cash (Debt)	8.28	10.73	4.52	31.4	38.76	52.48
Net Cash Growth	-22.78%	137.20%	-85.60%	-18.98%	-26.15%	252.17%
Net Cash Per Share	1.93	2.61	2.27	19.56	30.05	47.50
Book Value	16.67	18.2	13.46	13.22	50.84	68.09
Book Value Per Share	3.89	4.43	6.74	8.24	39.41	61.62
Tangible Book Value	0.33	1.83	3.01	-1.63	28.96	46.38
Tangible Book Value Per Share	0.08	0.44	1.51	-1.02	22.45	41.98

SEC Filings: 10-K · 10-Q